เพื่อพัฒนาเว็บไซต์ให้ดียิ่งขึ้น โปรดสละเวลา 1 นาที ในการตอบแบบสอบถามจากเรา Click !!

บุคลากรอาจารย์อาวุโส


รศ.ดร.ภญ. จุฑามณี สุทธิสีสังข์

รศ.ดร.ภญ. จุฑามณี สุทธิสีสังข์

chuthamanee.sut@mahidol.ac.th

chuthamanee.sut@mahidol.ac.th
อาจารย์ประจำภาควิชาเภสัชวิทยา , รองอธิการบดี

ผลงานวิจัยตีพิมพ์

2021

  1. Incidence and clinical manifestation of iatrogenic opioid withdrawal syndrome in mechanically ventilated patients
    Taesotikul S, Dilokpattanamongkol P, Tangsujaritvijit V, Suthisisang C*. Current Medical Research and Opinion 2021; 37(7) : 1213-1219.

  2. Medicinal cannabis in Thailand: 1-year experience after legalization
    Zinboonyahgoon N, Srisuma S, Limsawart W, Rice ASC, Suthisisang C. Pain 2021; 162: 105-109.

  3. Strategies for the use of Ginkgo biloba extract, EGb 761®, in the treatment and management of mild cognitive impairment in Asia: Expert consensus
    Kandiah N*, Chan YF, Chen C, Dasig D, Dominguez J, Han S-H, Jia J, Kim S, Limpawattana P, Ng L-L, Nguyen DT, Ong PA, Raya-Ampil E, Saedon N, Senanarong V, Setiati S, Singh H, Suthisisang C, Trang TM, Turana Y, Venketasubramanian N, Yong FM, Youn YC, Ihl R. CNS neuroscience and therapeutics 2021; 27(2): 149-162.


2019

  1. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
    Kandiah N*, Ong PA, Yuda T, Ng L-L, Mamun K, Merchant RA, Chen C, Dominguez J, Marasigan S, Ampil E, Nguyen VT, Yusoff S, Chan YF, Yong F.M., Krairit O, Suthisisang C, Senanarong V, Ji Y, Thukral R, Ihl R. CNS Neuroscience and Therapeutics 2019; 25(2): 288-298.


2018

  1. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
    Samseethong T, Suansanae T, Veerasarn K, Liengudom A, Suthisisang C. Annals of Pharmacotherapy 2018; Article in Press.

  2. In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β
    Luangmonkong T., Suriguga S., Adhyatmika A., Adlia A., Oosterhuis D., Suthisisang C., de Jong K.P., Mutsaers H.A.M., Olinga P. Toxicology and Applied Pharmacology 2018; 355; 127-237

  3. Symptomatic orthostatic hypotension in parkinson’s disease patients: prevalence, associated factors and its impact on balance confidence
    Klanbut S, Phattanarudee S*, Wongwiwatthananukit S, Suthisisang C, Bhidayasiri R. Journal of the Neurological Sciences 2018; 385: 168-174

  4. UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder
    Hongkaew Y, Medhasi S, Pasomsub E, Ngamsamut N, Puangpetch A, Vanwong N, Chamnanphon M, Limsila P., Suthisisang C, Wilffert B, Sukasem C.* Pharmacogenomics Journal 2018; 1-9


2017

  1. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer’s disease
    Kim S.H., Kandiah N., Hsu J.-L., Suthisisang C, Udommongkol C, Dash A. British Journal of Pharmacology. 2017; 174(23): 4224-4232. 2017; 174(23): 4224-4232.

  2. Impact of pharmaceutical care on pain and agitation in a medical intensive care unit in Thailand
    Dilokpattanamongkol P, Tangsujaritvijit V, Suansanae T, Suthisisang C*. International Journal of Clinical Pharmacy 2017; 39(3): 573-581.

  3. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study
    Wongpakaran R, Suansanae T*, Tan-khum T, Kraivichian C, Ongarjsakulman R, Suthisisang C. Journal of Clinical Pharmacy and Therapeutics 2017; 42(3): 329-336.

  4. Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents
    Nuntamool N, Ngamsamut N, Vanwong N, Puangpetch A, Chamnanphon M, Hongkaew Y, Limsila P, Suthisisang C, Wilffert B, Sukasem C*. Basic and Clinical Pharmacology and Toxicology 2017; 121(4): 316-324


2016

  1. Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer’s Disease in the Asia-Pacific Region
    Sabbagh M, Han S, Kim S, Na H-R, Lee J-H, Kandiah N, Phanthumchinda K, Suthisisang C, Senanarong V, Pai M-C, Narilastri D, Sowani AM, Ampil E, Dash A. Dementia and Geriatric Cognitive Disorders Extra 2016; 6(3): 382-395.

  2. Effects of mirtazapine on quality of life of Thai patients with fibromyalgia syndrome: A double-blind, randomized, placebo-controlled trial
    Suttiruksa S., Yeephu S., Prateepavanich P., Suthisisang C*. Asian Biomedicine 2016; 10(5): 435-445.

  3. ความชุก และลักษณะของภาวะความดันเลือดต่ำขณะเปลี่ยนอิริยาบถ ชนิดที่มีอาการทางคลินิกในผู้ป่วยไทย ที่เป็นโรคพาร์กินสัน
    สิรนันท์ กลั่นบุศย์, สิริพรรณ พัฒนาฤดี*, ศุภกิจ วงศ์วิวัฒนนุกิจ, จุฑามณี สุทธิสีสังข์, รุ่งโรจน์ พิทยศิริ. วารสารเภสัชกรรมไทย 2016; 8(1): 156-168.


2013

  1. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects
    Maenthaisong R, Tacconelli S, Sritara P, Del Boccio P, Di Francesco L, Sacchetta P, Archararit N, Aryurachai K, Patrignani P*, Suthisisang C. International Journal of Immunopathology and Pharmacology 2013; 26: 403-417

  2. Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study.
    Yeephu S, Suthisisang C, Suttiruksa S, Prateepavanich P, Limampai P, Russell IJ. Ann Pharmacother 2013; 47(7-8): 921-932

  3. Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: A case report
    Tan-kam T, Suthisisang C, Pavasuthipaisit C, Limsila P, Puangpetch A, Sukasem C*. Pharmacogenomics and Personalized Medicine 2013; 6(1): 3-7


2011

  1. Efficacy and safety of sumatriptan plus naproxen sodium in the acute treatment of migraine: Systematic review and meta-analysis of randomized controlled trials
    Suthisisang CC*, Poolsup N, Suksomboon N. Internet Journal of Pain, Symptom Control and Palliative Care 2011; 8(2): 1528-8277

  2. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes
    Suksomboon N*, Poolsup N, Boonkaew S, Suthisisang CC. Journal of Ethnopharmacology 2011; 137(3): 1328-1333


2010

  1. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine.
    Suthisisang C,* Poolsup N, Suksomboon N, Lertpipopmetha V, Tepwitukgid B. Headache 2010; 50(5): 808-818.

  2. Study of anti-inflammatory activities of the pure compounds from Andrographis paniculata (burm.f.) Nees and their effects on gene expression
    Parichatikanond W, Suthisisang C*, Dhepakson P, Herunsalee A. Int Immunopharmacol 2010; 10(11): 1361-1373.


2008

  1. Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels
    Phuntuwate W, Suthisisang C*, Koanantakul B, Chaloeiphap P, Mackness B, Mackness M. Atherosclerosis. 2008; 196(1): 122-128. Jan

  2. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring
    Uchaipichat V, Koanantakul B, Suthisisang C*. J Med Assoc Thai 2008; 91(9):1468-1477.


2007

  1. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis
    Suthisisang C*, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P. Ann Pharmacother 2007; 41(11) Nov: 1782-1791.


2006

  1. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats.
    Hirunpanich V, Utaipat A, Morales NP, Bunyapraphatsara N, Sato H, Herunsale A, Suthisisang C J Ethnopharmacol 2006;Jan 16;103(2):252-60

  2. Hypocholesterolimic and antioxidant effects of aqueous extracts from the dried calyx of Hibicus sabdariffa L. in hypocholesterolemic rats
    Hirupanich V, Utaipat A, Morales NP, Bunyapraphatsara N, Sato H, Herunsalee A, Suthisisang C*. Journal of Ethnopharmacology 2006;103:252-260


2005

  1. Antioxidant effects of aqueous extracts from dried calyx of Hibiscus sabdariffa Linn. (Roselle) in vitro using rat low-density lipoprotein (LDL)
    Hirunpanich V, Utaipat A, Morales NP, Bunyapraphatsara N, Sato H, Herunsalee A, Suthisisang C*. Biol Pharm Bull 2005 Mar;28(3):481-484

  2. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials.
    Poolsup N*, Suthisisang C, Channark P, Kittikulsuth W. Ann Pharmacother 2005; 39(6): 1080-7

  3. Paraoxonase 1 status in the Thai population.
    Phuntuwate W, Suthisisang C*, Koanantakul B, Mackness MI, Mackness B. J Hum Genet. 2005;50(6):293-300


2004

  1. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection : systematic review of randomized controlled trials.
    Poolsup N*, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. J Clin Pharm Ther 2004;29(1):37-45.


2000

  1. Alternative therapies and medical science : designing clinical trials of alternative/complementary medicines is evidence-based traditional Chinese medicine attainable ?
    Critcheley JA, Zhang F, Suthisisang C, et al. J Clin Pharmacol 2000; 40 (5): 462-7

  2. Risperidone versus halo-peridol treatment in first-episode schizophernic Thai patients.
    Choovanichvong S, Kitaroonchai W, Suthisisang C, et al. Journal of Psychiatric Association of Thailand 2000; 45 (2): 165-76


1998

  1. Bioavailability of phenytoin sodium capsules available in Thailand Part I: In vitro study.
    Suthisisang C, Payakacht N. J Med Assoc Thailand 1998;81 (1): 58-63

  2. Biovailability of phenytoin sodium capsules available in Thailand. Part II: In vivo study.
    Suthisisang C, Payakachat N, Chulavatnatol S, Towanabut T. J Med Assoc Thailand 1998; 81 (1): 64-70

  3. The period prevalence of catamenial epilepsy at Prasat Neurological Institute, Bangkok.
    Towanabut T, Chulavatnatol S, Suthisisang C, Wanakamanee U. J Med Assoc Thailand 1998;81(12):970-7


1994

  1. Metabolic profile of paracetamol in healthy Thais.
    Suthisisang C, Thiptavechan W, Angkatavanich J, Critchley JAJH. Internal medicine (Thai) 1994; 19 (3): 72-6



หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ รศ.ดร.ภญ. จุฑามณี สุทธิสีสังข์ ได้แก่ จุฑามณี สุทธิสีสังข์ ; Suthisisang C ;

คณะเภสัชศาสตร์ มหาวิทยาลัยมหิดล

447 ถนนศรีอยุธยา แขวงทุ่งพญาไท เขตราชเทวี กรุงเทพฯ 10400

ดูเบอร์ติดต่อหน่วยงานต่างๆ | ดูข้อมูลการเดินทางและแผนที่

เว็บไซต์นี้ออกแบบและพัฒนาโดย งานเทคโนโลยีสารสนเทศและสื่อการเรียนการสอน คณะเภสัชศาสตร์ มหาวิทยาลัยมหิดล
Copyright © 2013-2024
 

เว็บไซต์นี้ใช้คุกกี้

เราใช้เทคโนโลยีคุกกี้เพื่อช่วยให้เว็บไซต์ทำงานได้อย่างถูกต้อง การเปิดให้ใช้คุณสมบัติทางโซเชียลมีเดีย และเพื่อวิเคราะห์การเข้าเว็บไซต์ของเรา การใช้งานเว็บไซต์ต่อถือว่าคุณยอมรับการใช้งานคุกกี้